ID: ALA195605

Max Phase: Preclinical

Molecular Formula: C15H10F4O

Molecular Weight: 282.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C\c2cc(F)c(F)c(F)c2)cc1F

Standard InChI:  InChI=1S/C15H10F4O/c1-20-14-5-4-9(6-11(14)16)2-3-10-7-12(17)15(19)13(18)8-10/h2-8H,1H3/b3-2-

Standard InChI Key:  AVJZUVPZSSJOSY-IHWYPQMZSA-N

Associated Targets(Human)

Tubulin beta-1 chain 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 282.24Molecular Weight (Monoisotopic): 282.0668AlogP: 4.42#Rotatable Bonds: 3
Polar Surface Area: 9.23Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.73CX LogD: 4.73
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.46Np Likeness Score: -0.54

References

1. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP..  (2005)  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.,  48  (2): [PMID:15658859] [10.1021/jm049444m]

Source